This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Jones WG et al. (2005) Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I testicular seminoma: a report in Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942. J Clin Oncol 23: 1200–1208
Bokemeyer C et al. (2004) Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials. Br J Cancer 91: 683–687
Warde P et al. (2002) Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 20: 4448–4452
Aparicio J et al. (2004) Risk-adapted management of stage I seminoma: The second Spanish Germ Cell Cancer Group (GG) study. In J Clin Oncol, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition) 22 (Suppl 14S): 4518
Hofer MD et al. (2005) Identification of two molecular groups of seminomas by using expression and tissue microarrays. Clin Cancer Res 11: 5722–5729
Acknowledgements
The synopsis was written by Alexandra King, Assistant Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Bokemeyer, C. Is carboplatin as effective as radiotherapy for the adjuvant treatment of stage I seminoma?. Nat Rev Urol 2, 586–587 (2005). https://doi.org/10.1038/ncpuro0359
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpuro0359